Technical Analysis for MURA - Mural Oncology plc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 3.50 | 1.16% | 0.04 |
MURA closed up 1.16 percent on Friday, July 26, 2024, on 42 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Spinning Top | Other | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 1.16% | |
| Overbought Stochastic | Strength | 1.16% | |
| 50 DMA Support | Bullish | 2.04% | |
| Overbought Stochastic | Strength | 2.04% | |
| 50 DMA Support | Bullish | 1.45% |
| Alert | Time |
|---|---|
| Up 2% | about 10 hours ago |
| Up 1% | about 10 hours ago |
| Possible Pocket Pivot | 1 day ago |
| 10 DMA Support | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Our expertise in cytokine biology and immune cell modulation and our unmatched protein engineering will enable us to develop medicines that deliver meaningful and clinical benefits to people living with cancer. Our mission is to broaden the potential and reach of cytokine-based immunotherapies to improve the lives of patients. Mural Oncology has its registered office in Dublin, Ireland, and its primary facilities in Waltham, Mass.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunotherapy Treatment Of Cancer Oncology Virotherapy Immunotherapies Cytokine Protein Engineering
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunotherapy Treatment Of Cancer Oncology Virotherapy Immunotherapies Cytokine Protein Engineering
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.0 |
| 52 Week Low | 2.88 |
| Average Volume | 209,368 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 3.36 |
| 20-Day Moving Average | 3.26 |
| 10-Day Moving Average | 3.43 |
| Average True Range | 0.16 |
| RSI (14) | 62.41 |
| ADX | 24.96 |
| +DI | 20.43 |
| -DI | 10.00 |
| Chandelier Exit (Long, 3 ATRs) | 3.10 |
| Chandelier Exit (Short, 3 ATRs) | 3.35 |
| Upper Bollinger Bands | 3.64 |
| Lower Bollinger Band | 2.88 |
| Percent B (%b) | 0.82 |
| BandWidth | 23.40 |
| MACD Line | 0.05 |
| MACD Signal Line | 0.01 |
| MACD Histogram | 0.0389 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.65 | ||||
| Resistance 3 (R3) | 3.65 | 3.59 | 3.63 | ||
| Resistance 2 (R2) | 3.59 | 3.56 | 3.60 | 3.62 | |
| Resistance 1 (R1) | 3.55 | 3.53 | 3.57 | 3.55 | 3.61 |
| Pivot Point | 3.49 | 3.49 | 3.51 | 3.50 | 3.49 |
| Support 1 (S1) | 3.45 | 3.46 | 3.47 | 3.45 | 3.39 |
| Support 2 (S2) | 3.39 | 3.43 | 3.40 | 3.38 | |
| Support 3 (S3) | 3.35 | 3.39 | 3.38 | ||
| Support 4 (S4) | 3.35 |
